Natco Pharma and Lupin gained FDA approval for bioequivalent generic eribulin mesylate injection, potentially reducing ...

CIPN is a common nerve-damaging side effect of chemotherapy with no FDA-approved treatment options Fast Track designation reflects the significant unmet need and enables potential accelerated drug ...

Cancer Res (1968) 28 (5): 811–822. A large cooperative study to obtain quantitative information about the use of cyclophosphamide and the vinca alkaloids as therapeutic agents in patients with ...

Stroke is a life-threatening event in which part of the brain does not receive enough oxygen, usually because of a blood clot blocking an artery in the brain. Stroke is the third leading cause of ...

Neuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy among patients with cancer. Neuromuscular training, including sensorimotor training (SMT) and whole-body ...

St. Jude Children's Research Hospital scientists have identified specific DNA variants in the non-coding regions of the genome contributing to chemotherapy resistance in acute lymphoblastic leukemia ...

A recent, bizarre murder case in Minnesota involved a physician (a poison expert) accused of poisoning his wife with a toxic gout drug called colchicine. The fact that she didn’t have gout, and that ...